Repeated or prolonged anesthesia to pregnant women disturbs neurodevelopment of developing infants, but its mechanism has not been elaborated absolutely. This study was conducted to investigate the mechanism of potential neurotoxicity on their offspring generation after sevoflurane anesthesia in adult animals during pregnancy based on metabolomics. 16 pregnant rats were equally assigned to sevoflurane group and control group, and serum samples were collected from their 7-day-old offspring for metabolomics analysis using ultra performance liquid chromatography coupled to time-of-flight mass spectrometry. Principal component analysis and partial least squares-discriminate analysis were used for pattern recognition, and pathway analysis was performed by MetaboAnalyst platform. 29 metabolites were discovered as neurotoxicity related-biomarkers, among which S-Adenosylmethioninamine was inhibited dramatically after sevoflurane exposure. Prenatal exposure to sevoflurane led to a significant reduction in S-Adenosylmethionine level, as shown by enzyme-linked immunosorbent assay. Pathway analysis highlighted that prenatal exposure to sevoflurane induced alteration in arginine/proline metabolism, cysteine/methionine metabolism, and so on. The most important altered metabolic pathway was arginine/proline metabolism. This study suggests that abnormal methylation and disturbed arginine/proline metabolism may crucially contribute to the mechanism with neurotoxicity on offspring generation after sevoflurane anesthesia in adult animals during pregnancy, and dietary supplement of SAdenosylmethionine and modulating arginine/proline metabolism may be the potential therapeutic targets for protecting neurodevelopment from detrimental effects of prenatal exposure to inhalational anesthetics.
Introduction
In 2016, Food and Drug Administration has announced that repeated or prolonged anesthesia to children or pregnant women impeded neurodevelopment of developing infants, but the underlying mechanism remains unclear at large. Sevoflurane is a commonly used inhalational anesthetic in clinic, especially in pediatric surgery, for its practical convenience, anesthetic efficacy, and lower respiratory stimulation; whereas, it might cause behavioral impairment in developing brain (Satomoto et al., 2009 ). There are evidences indicated that the pathological mechanism may involve oxidative stress (Yufune et al., 2016) , neuroapoptosis (Kodama et al., 2011) , neuroinflammation (Shen et al., 2013; Zhang et al., 2013; Wang et al., 2014) , altered synaptic properties (Zhang et al., 2015) and especially, increased Tau (Tao et al., 2014) which is generally accepted as an important functional protein in neurodegenerative diseases in plenty of reports (Min et al., 2015; Scheltens et al., 2016) . At a degree, these studies revealed the mechanism in part; which is, however, focusing on only certain or limited functional biomolecules, and may not sufficient to understand such an extremely complicated biological process. A global and comprehensive research strategy is thus mostly needed. Metabolomics, which provides fundamental causes of diseases (Wishart, 2016) and profiling of metabolites in integrated living system responding to potential factors, may give us a new insight into this pathological mechanism. Scholars have employed metabolomics to investigate the mechanism concerning sevoflurane-induced neurotoxicity and found that neonatal exposure to sevoflurane disrupted glucose, lipid, and amino acids metabolism (Liu et al., 2015a; Liu et al., 2015b ) and decreased N-acetylaspartate (Makaryus et al., 2015) in developing brain.
Till now, most metabolomics studies focus on the neurotoxicity of developing brain after sevoflurane anesthesia in neonatal animals, while pay rare attention to the potential neurotoxicity on their offspring generation after sevoflurane anesthesia in adult animals during pregnancy. Clinically, infants may indirectly suffer neurotoxicity from sevoflurane exposure to their mothers, and it is better worth attention to the effects of maternal sevoflurane anesthesia on their offspring. In 2013, Zheng H found that prenatal exposure to sevoflurane led to neurodevelopmental impairment in offspring (Zheng et al., 2013) , and its mechanism might relate to neuroinflammation, neuroapoptosis and decreased synaptic function, but a global and comprehensive understanding on the potential neurotoxicity is still needed.
In this study, pregnant rats were subjected to sevoflurane, and serum samples collected from their offspring generation were analyzed using ultra performance liquid chromatography coupled to time-offlight mass spectrometry (UPLC/TOF-MS) based metabolomics. This work may offer a global and comprehensive understanding on the potential neurotoxicity of prenatal exposure to sevoflurane on offspring.
Materials and methods

Animals and reagents
Animal protocol was approved by Institutional Animal Care and Use Committee (IACUC) in Shanghai Jiao Tong University (Permit Number: A2016077), and all procedures performed in studies were in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. 16 SpragueDawley rats within 15-16 days of gestation (400-500 g weighing) were purchased from Laboratory Animal Center of Shanghai Jiao Tong University and acclimated for 3 days, and the animals were individually housed in a standard environment with a 12-h light/dark cycle, 18-23°C temperature and 40%-70% humidity. The rats were given ad libitum access to food and water. HPLC-grade acetonitrile and formic acid were purchased from Merck made in USA. Calibration solution for TOF-MS was purchased from AB SCIEX (AB SCIEX, Foster City, USA). Ultrapure water was generated by a Milli-Q purified water system (Millipore, USA). Enzyme-linked immunosorbent assay kit was purchased from Cloud-Clone Corporation (Wuhan, China, catalog No.: L170620759).
Experimental protocol
16 Sprague-Dawley rats within 18-19 days of gestation were equally assigned to sevoflurane group (S group) and control group (C group). In S group, pregnant rats were treated with 2% sevoflurane carried by 100% oxygen for 6 h. The total gas flow was set as 4L/min. Temperature and humidity were kept at 30 ± 1°C and 50 ± 10%, respectively, during anesthesia in chamber. The concentrations of oxygen, carbon dioxide and sevoflurane were monitored by a gas analyzer (Drager, Lübeck, Germany). For C group, rats were dealt with the identical condition without sevoflurane.
In both S group and C group, half of rats (n = 4 in each group) were used for arterial blood gas analysis. Arterial blood samples from pregnant rats in S group were collected from abdominal aorta immediately after termination of anesthesia and analyzed by i-STAT 1 Analyzer (MN:300-G, Abbott Park, USA), and pregnant rats in C group were anesthetized with sevoflurane for short-term time prior to acquiring arterial blood for analyzing.
Remaining rats (n = 4 in each group) stayed in chamber waiting for delivery, and their offspring were used for metabolomics analysis and enzyme-linked immunosorbent assay. 43 and 48 offspring, respectively, were born from maternal rats in S group and C group, and no morbidity or fetal demise was found. Totally 26 postnatal-7-day rats were randomly selected from offspring generation in both groups (n = 13 in each), and decapitated after short-term sevoflurane anesthesia for collecting serum samples and hippocampus samples. Serum samples were stored in −80°C for further metabolomics experimentation, and hippocampus samples for enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay
Levels of S-Adenosylmethionine in hippocampus were measured by enzyme-linked immunosorbent assay. In brief, hippocampus samples were homogenized with normal saline, and then the homogenate was centrifuged (10,000g, 5 min, 4°C). The supernatants were collected for measuring S-Adenosylmethionine according to the manufacturer's instructions.
UPLC/TOF-MS analysis
50 μL thawed serum was precipitated with 400 uL acetonitrile and then vortex vigorously. After centrifugation (15000g, 15 min, 4°C), the supernatant was collected for UPLC/TOF-MS analysis. 6 pooled samples from a total of 26 serum samples were used for quality control (QC) analyzing, and QC samples analyzed at every 5 injection intervals. All samples were analyzed in both positive and negative ion modes.
An ACQUITY UPLC BEH C18 column (100 mm × 2.1 mm, 1.7 μm; Waters, USA) and a guard column (Waters, USA) were used, at 30°C column temperature. Injection volume was 2 uL in positive ion mode and 5uL in negative ion mode. The mobile phase consisted of solvent A (ultrapure water and 0.1% formic acid) and solvent B (100% acetonitrile). The gradient was as following: 0-1 min, 98% A, 2% B; 3 min, 50% A, 50% B; 12 min, 45% A, 55% B; 17 min, 20% A, 80% B; 20-25 min, 10% A, 90% B; 26 min, 0% A, 100% B. Flow rate was 0.4 mL/min.
Mass spectrometric parameters were as following: positive ion mode: ion spray voltage, 5.5 kV; ion source temperature, 500°C; declustering potential, 80 eV; collision energy, 35 eV; collision energy spread, 15 eV; the curtain gas, ion source gas 1 and ion source gas 2 were set at 20, 50, 50 psi, respectively; negative ion mode: ion spray voltage, 4.5 kV; ion source temperature, 500°C; declustering potential, 100 eV; collision energy, −35 eV; collision energy spread, 15 eV; the curtain gas, ion source gas 1 and ion source gas 2 were set at 20, 50, 50 psi, respectively. In both positive and negative ion modes, the IDA model was used, and it was composed of a TOF-MS survey scan (100-2000 m/z) followed by 6 TOF-MS/MS scans (100-1500 m/z) with the accumulation time of 0.08 s and 0.1 s, respectively.
Pattern recognition
Prior to metabolomics analysis, original data was pre-processed and normalized to total area to rectify the concentration bias of each sample, using MarkerView Software (AB SCIEX, Foster City, USA). The processed data was subjected to perform sample classification via principal component analysis (PCA) and partial least squares-discriminate analysis (PLS-DA) by SIMCA-P 11.5 Software. The potential biomarkers were discovered by PLS-DA, and were then structural identified by the Human Metabolome Database (HMDB) combined with PeakView Software (AB SCIEX, Foster City, USA). Finally, candidates were verified by statistical analysis.
Statistical analysis
All data were expressed as mean ± standard error of mean (S.E.M.). Statistical analysis was performed by independent Student's ttest using SPSS 19.0, and p < 0.05 was considered significantly.
Results
Arterial blood gas analysis
Rats treated with sevoflurane in S group might be impaired by major factors of sevoflurane per se, or arterial blood gas alterations, or both. Arterial blood gas analysis was performed here to eliminate the possibility of arterial blood gas alterations. As shown in Table 1 , pH value, arterial oxygen tension and arterial carbon dioxide tension displayed no significant variance between two groups. Rats in S group were only impaired by sevoflurane but not alterations in arterial blood gas caused by sevoflurane anesthesia; hence, the established animalmodel was acceptable.
UPLC/TOF-MS
In this study, UPLC/TOF-MS analysis was performed in both positive and negative ionization modes to acquire metabolomics profiles. Representative base peak chromatogram (BPC) was presented in Fig. 1A 163_3.42, 494.321_6.91, 544.3356_8.27, 496.336_10.11, 522.3514_11.51, 524.3680_15.24, 352.3191_16.30, 654.326_17.91, 806.5615_20.69, 338 .3391_21.51 in positive ion mode) were extracted to evaluate variances of the retention time and peak intensity. RSDs of retention times were less than 1.42%, and RSDs of peak intensities ranged from 1.66% to 4.96%, indicating that the proposed method of UPLC/TOF-MS profiling is acceptable.
In both positive and negative ion modes, BPC profiles almost display no difference between samples of S and C groups, and thus multivariate data analysis should be conducted.
Multivariate data analysis
PCA was performed on data of UPLC/TOF-MS profiles of samples in both groups, but provided poor separation for S and C groups in score plot (Fig. not shown) . Therefore, PLS-DA, a supervised method, was then performed and much better separation was acquired in either negative (Fig. 1B , one sample in C group was too few to be analyzed, three outliers in S group were excluded) and positive ion mode (Fig. 1C) . Three parameters were used to evaluate the performance of PLS-DA model, as following: in negative ion mode: R 2 X, over 76%; R 2 Y, over 96%; Q 2 (cum), over 91%; in positive ion mode: R2X, over 62%; R2Y, over 91%; Q2 (cum), over 81%. The results demonstrated that the PLS-DA model was acceptable.
Potential biomarkers
Variable importance in the projection (VIP) in PLS-DA was commonly used to discover the potential neurotoxicity-related biomarkers. 29 endogenous metabolites (VIP > 1), such as lipids, amino acids and peptides, bile acids, organic acid, were identified to be potential biomarkers in this study (listed in Table 2 ). Among these metabolites, 15 metabolites were up-regulated and 14 metabolites were down-regulated after prenatal exposure to sevoflurane.
As shown in Table 2 , many biomarkers, including (R)-1,2-dimethyl-5,6-dihydroxy-tetrahydroisoquinoline (Nagatsu, 1997) , L-3-Hydroxykynurenine (Kennedy et al., 2017; Notarangelo and Pocivavsek, 2017) and TG(22:0/22:6) (Proitsi et al., 2017) , have been reported to be associated with some neurodegenerative diseases, such as Parkinson's disease, Huntington's disease, Alzheimer's disease, motor neuron disease, multiple sclerosis. Some other biomarkers, including S-Adenosylmethioninamine (Strous et al., 2009; Sarris et al., 2014) , 5-Aminopentanoic acid (Dhaher et al., 2014) , Oleanolic acid , L-3-Hydroxykynurenine (Notarangelo and Pocivavsek, 2017), Leukotriene E4 (Black and Hoff, 1985) , TG(22:0/22:6) (Naiberg et al., Parkinson's disease (Nagatsu, 1997) 11. 2016; van Velzen et al., 2017) , have been proposed to be related to mental disorders. Oleanolic acid , Leukotriene E4 (Black and Hoff, 1985) , and TG(22:0/22:6) ( van Velzen et al., 2017) have been documented to be concerned with cognitive ability. Allantoin (Ahn et al., 2014) and Cholic acid (Theofilopoulos et al., 2013) were associated with neurogenesis. LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)) (Sundaram et al., 2012; Guillemot-Legris et al., 2016) has been reported to be related to neuroinflammation. Although many of these biomarkers have been reported, we also found some other biomarkers were concerned with neurotoxicity induced by prenatal exposure to sevoflurane in this study.
In our results, especially, we detected an important biomarker of SAdenosylmethioninamine, which can only be detected in samples of C group but absolutely disappeared after sevoflurane exposure (S group).
Effect of sevoflurane on the level of S-Adenosylmethionine
As S-Adenosylmethioninamine is the most important biomarker and derived from its upstream S-Adenosylmethionine, we hypothesize that prenatal exposure to sevoflurane may cause alteration in level of SAdenosylmethionine.
To confirm our consumption, SAdenosylmethionine level was measured. The enzyme-linked immunosorbent assay was used to detect S-Adenosylmethionine level in hippocampus after prenatal exposure to sevoflurane. Compared with C group, prenatal exposure to sevoflurane led to a significant reduction of S-Adenosylmethionine level in the hippocampus (Fig. 2) .
Pathway analysis
The 29 identified biomarkers were subjected to the analysis system of MetaboAnalyst (http://www.metaboanalyst.ca) for further pathways investigation. Fig. 3 highlighted 8 metabolic pathways including arginine/proline metabolism, porphyrin/chlorophyll metabolism, cysteine/ methionine metabolism, glycerophospholipid metabolism, tryptophan metabolism, biosynthesis of unsaturated fatty acids, primary bile acid biosynthesis, aminoacyl-tRNA biosynthesis. In these metabolic pathways, arginine/proline metabolism (Patin et al., 2016b) , cysteine/methionine metabolism , Chung et al., 2016 , glycerophospholipid metabolism (Paglia et al., 2016) , tryptophan metabolism (Rajamani et al., 2017) , biosynthesis of unsaturated fatty acids (Wu et al., 2016) , primary bile acid biosynthesis (Brito et al., 2008) and aminoacyl-tRNA biosynthesis have been demonstrated to be concerned with neurotoxicity. Undoubtedly, Fig. 3 indicated that arginine/proline metabolism was the most important metabolic pathway contributed to the mechanism with neurotoxicity on offspring generation after sevoflurane anesthesia in adult animals during pregnancy.
Discussion
Numerous studies on neurotoxicity of sevoflurane anesthesia in neonatal animals on developing brain have been conducted, and postnatal-7-day animals were commonly selected as model since brain growth spurted at postnatal days 6-8 (Diaz and Samson, 1980) . Nevertheless, neurogenesis begins from embryonic period, which is also essential for neurodevelopment and should be concerned. Maternal sevoflurane anesthesia may impose an indirect threat to neurodevelopment in their spring. So far, only very few works reported that sevoflurane exposure during embryonic period had detrimental effects on neurodevelopment (Zheng et al., 2013; Suehara et al., 2016; Fang et al., 2017) , but it lacks of global and comprehensive understanding. In this study, we select pregnant rats as a model to investigate potential neurotoxicity of sevoflurane anesthesia in adult rats during pregnancy on offspring generation by metabolomics, and it may give us a new insight into this complex process.
Many works indicated that abnormal methylation was closely associated with neurological diseases (Miller, 2008) . Our data suggests SAdenosylmethioninamine is the most important biomarker, which is derived from S-Adenosylmethionine (http://www.genome.jp/kegg/ pathway.html) that acts as a methyl donor in many fundamental metabolic processes. In samples of S group, S-Adenosylmethioninamine can not be observed, and S-Adenosylmethionine level was reduced after prenatal exposure to sevoflurane as shown in Fig. 2 , indicating that sevoflurane might induce abnormal methylation in offspring. Abnormal methylation leads to many diseases, including neuroinflammation (Nicolia et al., 2017) . In this study, presence of leukotriene E4 might hint that prenatal exposure to sevoflurane caused neuroinflammation in offspring. Meanwhile, since inflammatory genes were regulated by methylation in neurodegenerative diseases (Nicolia et al., 2017) , it was plausible that methylation served as a crucial role between neuroinflammation and neurotoxicity, and this assumption has been partially confirmed (Zhu et al., 2017) . Abnormal methylation occurred at the level of DNA and amino acid was concerned with neurological disability (Blanc and Richard, 2017; The data were expressed as mean ± S.E.M. The level of S-Adenosylmethionine was decreased after prenatal exposure to sevoflurane (C group: 56.17 ± 2.55 ng/g, S group: 45.53 ± 1.81 ng/g, n = 12 in each group), **p < 0.01 Fig. 3 . Overview of pathway analysis for the identified biomarkers. Pathway analysis was performed in MetaboAnalyst Platform (http://www. metaboanalyst.ca) X-axis represents metabolic pathway impact on the basis of betweenness centrality measure. A: arginine/proline metabolism, B: porphyrin/chlorophyll metabolism, C: cysteine/methionine metabolism, D: glycerophospholipid metabolism, E: tryptophan metabolism, F: biosynthesis of unsaturated fatty acids, G: primary bile acid biosynthesis, H: aminoacyl-tRNA biosynthesis. The most significant metabolic pathway is arginine/proline metabolism. Long et al., 2017) . Dysfunctional methylation of DNA was associated with neuroinflammation (Nicolia et al., 2017) , and it has been recognized as a key regulator for many neurodegenerative diseases as well, including Alzheimer's disease (Do Carmo et al., 2016) and Parkinson's disease (Jowaed et al., 2010) . In terms of amino acid methylation, abnormal methylation of amino acid disturbed cysteine/methionine metabolism. In cysteine/methionine metabolism, Chung and Li suggested that the deceasing of S-Adenosylmethionine up-regulated the homocysteine level, which accelerated neuropathology of neurodegenerative disorders by increasing beta-amyloid and Tau levels Chung et al., 2016) ; on the other hand, impaired remethylation of homocysteine resulted from abnormal methylation prevented homocysteine translating into methionine (Robinson et al., 2016) which is often accompanied by neurodevelopmental disorders (Jadavji Nafisa et al., 2014) . As shown in Fig. 3 , cysteine/methionine metabolism was also an important metabolic pathway responsible for sevoflurane in addition to arginine/proline metabolism. It might suggest that prenatal exposure to sevoflurane disrupted cysteine/methionine metabolism resulting in increasing beta-amyloid and Tau levels, both of which led to neurological damage eventually. Overall, we propose that abnormal methylation of DNA and amino acid may involve in the mechanism with prenatal exposure to sevoflurane induced neurotoxicity.
Numerous data have demonstrated that both hypomethylation and hypermethylation of DNA were concerned with some neurological diseases (Long et al., 2017; Richetto et al., 2017) . Since DNA methylation shows functions because of its ability of regulating genes expression (Bansal and Pinney, 2017) , neurological diseases-related DNA hypomethylation or hypermethylation may be the results of the alteration of functional biomolecules mediated by some altered certain genes expression. Zhu Y et al. reported that hypermethylation of a certain DNA promoter up-regulated neuroinflammation after sevoflurane anesthesia in animal-model of endoplasmic reticulum stress occurred during the neonatal period (Zhu et al., 2017) . Although no proof associated with hypomethylation of DNA, it gives some support for the viewpoint of DNA hypermethylation in neurological damage after sevoflurane anesthesia at least in part.
Arginine/proline metabolism is an important metabolic pathway associated with neurodegenerative diseases (Patin et al., 2016b) , and arginine and proline have been proposed as potential biomarkers of Alzheimer's disease recently (Ibanez et al., 2012) . In present study, pathway analysis suggested that arginine/proline metabolism was the most important metabolic pathway in this process; in addition, arginine/proline metabolism was abnormal inflammation models (Drago et al., 2016; Patin et al., 2016a) , which might suggest that sevoflurane induced neuroinflammation followed by altered arginine/proline metabolism and led to neurological damage ultimately.
Both the roles of arginine metabolism and proline metabolism were related to neurological diseases. Arginine metabolism was proved to be concerned with neurodevelopment (Wu et al., 2009 ) and neurological diseases (Basso and Pennuto, 2015) . Arginine was an indispensable component for synthesis of nitric oxide (Ockelford et al., 2016) , and nitric oxide signaling improved synaptic plasticity in Alzheimer's disease (Chakroborty et al., 2015) . Herein, we propose that prenatal exposure to sevoflurane may alter synaptic plasticity by arginine metabolism resulting in neurodevelopmental impairment. In proline metabolism, proline was vital to functional Tau fragment (Ahuja et al., 2016) that was harmful to cognitive ability. Clearance of Tau has been proposed to be a therapeutic approach to treat neurodegenerative diseases (Lei et al., 2015) ; whereas, it might inhibited by proline (Yamada et al., 2015) resulting in neurological damage ultimately. In failed protein folding mechanism, substitutions of proline may alter activities of cyclophilin B and γ-secretase, both of which led to Alzheimer's disease (Ben-Gedalya et al., 2015; Zoltowska and Berezovska, 2017) . In our data, L-proline was also identified as a biomarker of neurotoxicity, and it suggests that sevoflurane induced neurotoxicity was the result of inhibiting clearance of Tau and altering activities of cyclophilin B and γ-secretase. Arginine/proline metabolism, which is tightly concerned with neurological diseases, may contribute to the mechanism of prenatal exposure to sevoflurane related neurotoxicity.
In summary, our data may provide an alternative strategy to further investigate the mechanism of neurotoxicity induced by inhalational anesthetics on developing brain; on the other hand, dietary supplement of S-Adenosylmethionine, which may be capable of regulating methylation, and modulating arginine/proline metabolism during pregnancy in clinic may be the potential therapeutic treatments for protecting neurodevelopment from detrimental effects of prenatal exposure to inhalational anesthetics.
Conclusion
UPLC/TOF-MS based metabolomics provided us more comprehensive information for understanding pathological process of neurotoxicity caused by prenatal exposure to sevoflurane. We highlight that prenatal exposure to sevoflurane disturbs methylation and arginine/ proline metabolism, which may impose adverse impacts on neurodevelopment of offspring and contribute to the mechanism with neurotoxicity on offspring generation after sevoflurane anesthesia in adult animals during pregnancy. Although further evidences are still needed, abnormal methylation and arginine/proline metabolism may provide alternative way for us understanding the mechanism of inhalational anesthetics-induced neurotoxicity. Regulating methylation and arginine/proline metabolism may be as the potential therapeutic treatments for preventing inhalational anesthetics from impairing neurodevelopment.
Conflict of interest
The authors declare that there is no conflict of interest.
